Results 41 to 50 of about 99,753 (275)

Chemotherapy combined with radiotherapy for successful treatment of angioimmunoblastic T-cell lymphoma: a case report

Journal of Medical Case Reports, 2020
Background The incidence of angioimmunoblastic T-cell lymphoma is rare worldwide, and it has a poor prognosis. There is no proven or standard first-line therapy that works for the majority of patients with angioimmunoblastic T-cell lymphoma because of ...
Yudi Xiong, Lei Yang, Jing Dai, Fuxiang Zhou, Yunfeng Zhou   +4 more
doaj   +1 more source

REACTIVE PLASMACYTOSIS AT THE ONSET OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA. CASE REPORT

Онкогематология, 2018
Angioimmunoblastic T-cell lymphoma is a rare T-cell lymphoproliferative disease with generalized lymphadenopathy, hepatosplenomegaly, intoxication and polyclonal hypergammaglobulinemia.
N. G. Chernova, M. N. Sinitsyna, A. M. Kovrigina, Y. V. Sidorova, I. V. Galtseva, S. A. Mar’ina, V. N. Dvirnyk, E. E. Zvonkov   +7 more
doaj   +1 more source

Angioimmunoblastic T-cell lymphoma unmasked by treatment with dupilumab. [PDF]

JAAD Case Rep, 2023
Choo ZY, Akinyemi AA, Cibull T, Mehlis S, Waldinger JB.   +4 more
europepmc   +2 more sources

Targeting the Inducible T-cell Costimulator (ICOS) in patients with Relapsed/Refractory T-Follicular Helper Phenotype Peripheral T-Cell and Angioimmunoblastic T-Cell Lymphoma.

Clinical Cancer Research, 2023
PURPOSE Proliferation of T-follicular helper (TFH) CD4+ T-cells is a postulated pathogenic mechanism for T-cell non-Hodgkin's lymphomas (T-NHL). The inducible T-cell costimulator (ICOS) is highly expressed by TFH, representing a potential target.
J. Chavez, F. Foss, B. William, J. Brammer, Sonali M. Smith, A. Prica, J. Zain, J. Tuscano, H. Shah, N. Mehta-Shah, P. Ramakrishnan Geethakumari, Ben X Wang, Stephanie Zantinge, Lisa Wang, Ling Zhang, A. Boutrin, Weiguang Zhao, Lily I. Cheng, N. Standifer, L. Hewitt, Enowmpey Enowtambong, Weiping Shao, Shringi Sharma, G. Carlesso, J. Moscow, L. Siu   +25 more
semanticscholar   +1 more source

Use of Rituximab in autoimmune hemolytic anemia associated with non-hodgkin lymphomas [PDF]

, 2011
The association between non-Hodgkin lymphomas and autoimmune disorders is a well-known event. Also autoimmune hemolytic anemia (AHA), although much more frequent in patients with chronic lymphocytic leukemia (CLL), has been described in this group of ...
Fozza, Claudio, Longinotti, Maurizio Roberto   +1 more
core   +4 more sources

Review of the biologic and clinical significance of genetic mutations in angioimmunoblastic T‐cell lymphoma [PDF]

, 2018
journal ...
CHIBA Shigeru, Fukumoto Kota, Nguyen Tran B., SAKATA-YANAGIMOTO Mamiko   +3 more
core   +2 more sources

The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation

Haematologica, 2010
Background T follicular helper (TFH) cells reside in the light zone of germinal centers and are considered the cell of origin of angioimmunoblastic T-cell lymphoma.
Teresa Marafioti, Jennifer C. Paterson, Erica Ballabio, Andreas Chott, Yasodha Natkunam, Manuel Rodriguez-Justo, Anne Plonquet, Socorro M. Rodriguez-Pinilla, Wolfram Klapper, Martin-L. Hansmann, Stefano A. Pileri, Peter G. Isaacson, Harald Stein, Miguel A. Piris, David Y. Mason, Philippe Gaulard   +15 more
doaj   +1 more source

Impact of Epstein-Barr Virus on Peripheral T-Cell Lymphoma Not Otherwise Specified and Angioimmunoblastic T-Cell Lymphoma

Frontiers in Oncology, 2022
Purpose The significance of Epstein-Barr virus (EBV) infections for the prognosis of patients with peripheral T-cell lymphomas (PTCLs), specifically angioimmunoblastic T-cell lymphoma (AITL) and PTCL not otherwise specified (PTCL-NOS), remains unclear ...
T. Kim, G. Min, Y. Jeon, S. Park, S. Park, Seung-Hwan Shin, Seung-Ah Yahng, J. Yoon, S. Lee, B. Cho, K. Eom, Yoo-Jin Kim, Seok Lee, Hee‐Je Kim, C. Min, Jong-Wook Lee, Seok-Goo Cho   +16 more
semanticscholar   +1 more source

Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets. [PDF]

, 2015
International audienceno ...
Arbion, F., Berger, F., Bossard, C., Canioni, D., Charlotte, F., Copin, M.C., Damaj, G., Dartigues, P., de Leval, L., Delarue, R., Delsol, G., Fabiani, B., Fataccioli, V., Gaulard, P., Gisselbrecht, C., Haioun, C., Jais, J.P., Lamant, L., Le Bras, F., Ledoux-Pilon, A., Martin, A., Molina, T., Montagne, K., Parrens, M., Patey, M., Peoch, M., Petit, B., Petrella, T., Picquenot, J.M., Rousselet, M.C., Rousset, T., Soubeyran, I., Tas, P., Thiebault, S., Tournilhac, O., Xerri, L.   +35 more
core   +4 more sources

Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma

Haematologica, 2016
CTLA4 and CD28 are co-regulatory receptors with opposite roles in T-cell signaling. By RNA sequencing, we identified a fusion between the two genes from partial gene duplication in a case of angioimmunoblastic T-cell lymphoma.
Hae Yong Yoo, Pora Kim, Won Seog Kim, Seung Ho Lee, Sangok Kim, So Young Kang, Hye Yoon Jang, Jong-Eun Lee, Jaesang Kim, Seok Jin Kim, Young Hyeh Ko, Sanghyuk Lee   +11 more
doaj   +1 more source